A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. The approach ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors. This is an ASCO Meeting ...
For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...
A team of researchers at the Georgia Institute of Technology and Emory University has developed a deep-ultraviolet (UV) ...
During early development, tissues and organs begin to form through the shifting, splitting, and growing of many thousands of cells. A team of researchers headed by MIT engineers has now developed a ...
CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic and musculoskeletal diseases (RMD). This and other cell-depleting approaches ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
During early development, tissues and organs begin to bloom through the shifting, splitting, and growing of many thousands of cells. A team of MIT engineers has now developed a way to predict, minute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results